Covestor Ltd Increases Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Covestor Ltd raised its position in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 69.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 981 shares of the company’s stock after purchasing an additional 401 shares during the period. Covestor Ltd’s holdings in HCA Healthcare were worth $399,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the business. Mesirow Financial Investment Management Inc. lifted its holdings in shares of HCA Healthcare by 17.2% during the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 762 shares of the company’s stock worth $310,000 after acquiring an additional 112 shares during the last quarter. Atria Investments Inc boosted its holdings in shares of HCA Healthcare by 14.8% in the 3rd quarter. Atria Investments Inc now owns 5,724 shares of the company’s stock worth $2,326,000 after purchasing an additional 736 shares in the last quarter. Assetmark Inc. raised its holdings in shares of HCA Healthcare by 5.5% during the 3rd quarter. Assetmark Inc. now owns 1,834 shares of the company’s stock valued at $746,000 after buying an additional 96 shares in the last quarter. Verdence Capital Advisors LLC increased its holdings in shares of HCA Healthcare by 0.7% in the third quarter. Verdence Capital Advisors LLC now owns 22,929 shares of the company’s stock worth $9,319,000 after buying an additional 153 shares during the period. Finally, Markel Group Inc. lifted its holdings in HCA Healthcare by 45.1% in the third quarter. Markel Group Inc. now owns 50,930 shares of the company’s stock worth $20,699,000 after buying an additional 15,825 shares during the period. 62.73% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

HCA has been the subject of a number of research analyst reports. Cantor Fitzgerald restated an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a research note on Tuesday, October 1st. StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Wells Fargo & Company increased their price target on shares of HCA Healthcare from $395.00 to $400.00 and gave the company an “equal weight” rating in a report on Wednesday. Oppenheimer lifted their target price on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a report on Monday, October 28th. Finally, UBS Group boosted their target price on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Five research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $379.17.

Check Out Our Latest Stock Report on HCA Healthcare

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $354.16 on Friday. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The stock’s fifty day moving average is $389.61 and its 200 day moving average is $356.03. The stock has a market cap of $89.71 billion, a P/E ratio of 15.90, a P/E/G ratio of 1.34 and a beta of 1.68. HCA Healthcare, Inc. has a one year low of $226.48 and a one year high of $417.14.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s payout ratio is 11.85%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.